Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01492257 · ClinicalTrials.gov registry record · NA

Shared Decision Making in Patients With Osteoarthritis of the Hip and Knee

A NA study of Knee Osteoarthritis and Hip Osteoarthritis, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
120
Enrollment target
2
Study locations

NCT01492257 is a NA study of Knee Osteoarthritis and Hip Osteoarthritis that has completed, run by University of California, San Francisco. The registered enrollment target is 120 participants, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (60% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01492257, a NA study of Knee Osteoarthritis and Hip Osteoarthritis, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
2
Study locations

Study Summary

Total joint arthroplasty (TJA) is an effective procedure for reducing pain and improving function in patients with disabling osteoarthritis (OA) of the hip or knee. However, as with all invasive procedures, TJA is associated with certain risks and substantial costs. Since the indications for TJA are heavily dependent on patients' quality of life and expectations. TJA utilization rates vary widely throughout the United States, as seen with other 'preference-sensitive' procedures. Early evidence suggests shared decision making (SDM) strategies are effective in enhancing patient decision quality, or the degree to which treatment decisions reflect the preferences of fully informed patients, especially for preference-sensitive procedures like TJA. Despite these advantages, however, SDM has not been embraced or widely adopted in orthopaedics. To investigate this limited uptake, the investigators propose a series of evaluations of individual-level strategies. The investigators innovative and unique contribution is to approach patients, surgeons and healthcare purchasers as having symmetric and equally valid concerns about the benefits and cost associated with SDM. The investigators overall objective is to facilitate wider dissemination of SDM strategies in orthopaedic practices. The specific aims of the project are to assess, for SDM strategies, the impact on key patient, surgeon, and healthcare purchaser priorities; By achieving this aim our project will produce new interventions and incentives for disseminating SDM that are endorsed as feasible and acceptable by a coalition of patients, surgeons, and purchasers. The investigators plans for evaluation include a randomized controlled trial to evaluate the impact of SDM on outcomes of interest to patients, surgeons, and purchasers.

Interventions

  • OTHER Shared Decision Making Intervention

Study Locations (2)

California

  • Stanford University - Redwood City
  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2011-07
Est. Completion 2012-08
Phase NA

What the Registry Record Tells You About NCT01492257

The ClinicalTrials.gov registry entry for NCT01492257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (60% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Shared Decision Making Intervention is the first listed.

NCT01492257 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01492257 about?

NCT01492257 is a clinical study titled "Shared Decision Making in Patients With Osteoarthritis of the Hip and Knee". Total joint arthroplasty (TJA) is an effective procedure for reducing pain and improving function in patients with disabling osteoarthritis (OA) of the hip or knee. However, as with all invasive procedures, TJA is associated with certain risks and substantial costs. Since the indications for TJA are...

What is the current status of trial NCT01492257?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2011-07. Estimated completion is 2012-08.

What conditions does trial NCT01492257 study?

This clinical trial studies the following conditions: Knee Osteoarthritis, Hip Osteoarthritis.

What interventions are being tested in trial NCT01492257?

The interventions under investigation include: Shared Decision Making Intervention (OTHER).

Who is sponsoring clinical trial NCT01492257?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01492257 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.